Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia

被引:12
作者
Aul, C
Gattermann, N
Germing, U
Sudhoff, T
Hollmig, KA
Heyll, A
机构
[1] Department of Internal Medicine, Hematology and Oncology Division, Heinrich Heine University, Düsseldorf
[2] Department of Internal Medicine, Hematology and Oncology Division, Heinrich Heine University, 40225 Düsseldorf
关键词
chronic myelomonocytic leukemia; myelodysplastic syndrome; hyperleukocytic syndrome; low-dose chemotherapy; microvascular hyperviscosity; pulmonary circulation; leukocyte adhesion molecules; MYELODYSPLASTIC SYNDROMES; PROGNOSTIC FACTORS; PROPOSALS; CLASSIFICATION; LEUCOSTASIS;
D O I
10.1016/S0145-2126(96)00117-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A 53-year-old male patient was admitted to our hospital with painful splenomegaly. He was diagnosed as having chronic myelomonocytic leukemia (CMML) with leukocytosis, monocytosis, increased lysozyme concentrations in serum und urine, and lack of the Philadelphia chromosome. The clinical course of the disease was characterized by rapidly rising leukocyte counts, cutaneous infiltrates, respiratory insufficiency and neurological symptoms. Excessive hyperleukocytosis with a significant increase in monocytic cells led to microcirculatory obstruction, vascular endothelial damage and organ malfunction. This complication could not be prevented by low-dose chemotherapy with cytosine arabinoside. The patient finally died from pulmonary and cerebral hyperleukocytic syndrome. (C) 1997 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 21 条
  • [1] AUL C, 1992, LEUKEMIA, V6, P52
  • [2] THE CHRONIC MYELOID LEUKEMIAS - GUIDELINES FOR DISTINGUISHING CHRONIC GRANULOCYTIC, ATYPICAL CHRONIC MYELOID, AND CHRONIC MYELOMONOCYTIC LEUKEMIA - PROPOSALS BY THE FRENCH-AMERICAN-BRITISH-COOPERATIVE-LEUKEMIA-GROUP
    BENNETT, JM
    CATOVSKY, D
    DANIEL, MT
    FLANDRIN, G
    GALTON, DAG
    GRALNICK, H
    SULTAN, C
    COX, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) : 746 - 754
  • [3] PROPOSALS FOR THE CLASSIFICATION OF THE MYELODYSPLASTIC SYNDROMES
    BENNETT, JM
    CATOVSKY, D
    DANIEL, MT
    FLANDRIN, G
    GALTON, DAG
    GRALNICK, HR
    SULTAN, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1982, 51 (02) : 189 - 199
  • [4] EVERSON MP, 1989, BLOOD, V74, P1472
  • [5] FOUCAR K, 1985, CANCER-AM CANCER SOC, V56, P553, DOI 10.1002/1097-0142(19850801)56:3<553::AID-CNCR2820560323>3.0.CO
  • [6] 2-Q
  • [7] LEUCOSTASIS SYNDROME
    GATTERMANN, N
    SCHNEIDER, W
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1991, 116 (37) : 1399 - 1404
  • [8] GELLER SA, 1971, ARCH PATHOL, V91, P573
  • [9] GERMING U, 1994, BLOOD S, V84, P1243
  • [10] UTILITY OF THE FAB CLASSIFICATION FOR MYELODYSPLASTIC SYNDROMES - INVESTIGATION OF PROGNOSTIC FACTORS IN 237 CASES
    KERKHOFS, H
    HERMANS, J
    HAAK, HL
    LEEKSMA, CHW
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (01) : 73 - 81